million. Due to total revenues decreased of Baht 554.20 million mainly from brokerage fees decreased of Baht 282.56 million, Gain and return on financial instruments decreased of Baht 326.45 million and
pressuring net profit margin 2) higher depreciation resulted from additional investments in plant, machinery, and office renovations to improve production efficiency and reduce production cost, in order to
investment in machinery to improve production efficiency and reduce production cost, in order to prepare for an increased level of production in the future. Q3/2017 net profit rebounded remarkably by 27% QoQ
through Company Private Fund showing 21.55% higher return on investment, Baht 8.76 million upside from the business acquisition of scientific analytical and diagnostic for medical services, and gained of
from the return of stabilization function payment, which the company filed to Administrative Court. The Company recorded the revenue of THB 156 million while 1st quarter 2018, the Company does not have
return on investment in private funds amount of THB 12.02 million, an increase of THB 11.72 million or 3,907 per cent. The profit from investment in associated company amount of THB 3.27 million, a
Ratio 12 Months 2019 12 Months 2018 Gross Profit Margin (%) 42.3 43.8 Net Profit Margin (%) 4.3 5.2 Return on Asset (%) 7.9 10.0 Return on Equity (%) 12.3 15.4 Current Ratio (Times) 1.7 1.6 Debt to Equity
). Revenue has increased 1.26 million baht (ratio 2.45%) due to sale local increased by 0.96 million baht, increasing return estimates 0.46 million baht, rental income increased 0.54 million baht, other
profit in 2Q17. Key Financial Ratio Financial ratio 2Q16 1Q17 2Q17 Current ratio 0.58 0.52 0.54 Debt to Equity ratio 1.53 2.00 1.91 Interest Bearing Debt to Equity ratio 0.40 0.58 0.67 Return on Asset 19.3
return value at 0.0295 (calculated from the financial statements ended as June 30, 2017), For this issue, the transaction is not classified as either a connected transaction and transaction size is not the